Paul Tudor Jones Pulmonx Corp Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Pulmonx Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 149,102 shares of LUNG stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149,102
Previous 136,820
8.98%
Holding current value
$1.29 Million
Previous $1.13 Million
10.76%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$47.5 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$26.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$19.7 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$13.2 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $321M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...